WHO infant malaria drug approval 2026

WHO Infant Malaria Drug Approval 2026: First-Ever Treatment for Newborns Announced by WHO on World Malaria Day

WHO infant malaria drug approval 2026 marks a historic breakthrough as the World Health Organization approves the first-ever malaria treatment specifically designed for newborns and infants, improving global child health and malaria control efforts. WHO Approves First-Ever Infant-Specific Malaria Drug on World Malaria Day 2026 🧪 WHO’s Historic Approval of Infant-Specific Malaria Drug The World…

Read More